Please login to the form below

CoStim Pharmaceuticals

This page shows the latest CoStim Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Novartis enters PD-1 race via CoStim acquisition

Expands presence in cancer immunotherapies. Novartis has reached a deal to acquire US company CoStim Pharmaceuticals, expanding its position in the hot topic of cancer immunotherapy. ... Boston, Massachusetts-based CoStim - which started operations in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Senior Editorial Assistant – Greater Manchester: DOE

Principal Health Economist - North-West: Negotiable

Senior Account Manager: Competitive Salary Offered

Account Director: Competitive Salary Offered

Associate Director: £75, 000-90, 000

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Systematic Reviewer - Oxford: Negotiable

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Executive/ Senior Account Executive: competitive Salary Offfered

Medical (Scientific) Director: £120, 000 benefits

Healthcare Communications Account Directors x 2: Salary TBC

Experienced Medical Writers: Competitive Salary and Benefits

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Manager: Negotiable

Business Development Director – Health Education: excellent commission

Editorial Manager - MedComms: DOE

Account Manager- Healthcare Advertising: Negotiable

Account Manager / Account Director: Competative

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager / Senior Account Manager: 35, 000-40, 000

Medical Writer: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...